Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible content changes on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.4.2 and the government funding status notice was removed; no study content or eligibility criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:12:44.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a site-wide status notice about a lapse in government funding and the NIH Clinical Center’s operations, and updated the site version to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    New UI elements were added: a glossary toggle, a 'Last Update Submitted that Met QC Criteria' entry, a 'No FEAR Act Data' notice, and a revision tag showing v3.4.0. The prior items—'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4—were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:18:19.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:24.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section with Maryland and Pennsylvania entries and updated the page revision to v3.3.3. Removed the Maryland Locations and Pennsylvania Locations sections and the HHS Vulnerability Disclosure link, replacing revision v3.3.2 with v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T12:32:30.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.